Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone
暂无分享,去创建一个
B. Burkey | C. Reddy | S. Koyfman | D. Adelstein | E. Lamarre | M. Ward | J. Greskovich | T. Nwizu | P. Bhateja | John F. Greskovich | David J. Adelstein | Grant H. Hunter | Tobenna I. Nwizu
[1] Christopher U. Jones,et al. Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512). , 2014, International journal of radiation oncology, biology, physics.
[2] Christopher U. Jones,et al. Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. , 2014, International journal of radiation oncology, biology, physics.
[3] A. Al-Mamgani,et al. Radiotherapy for T1‐2N0 glottic cancer: a multivariate analysis of predictive factors for the long‐term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients , 2013, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[4] R. Weber,et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] C. Reddy,et al. Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: a 20 year Cleveland clinic experience , 2012, Radiation oncology.
[6] Y. Horikawa,et al. Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005 , 2012, Radiation oncology.
[7] W. Mendenhall,et al. Prognostic Significance of Paraglottic Space Invasion in T2N0 Glottic Carcinoma , 2007, American journal of clinical oncology.
[8] K. Ang,et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Y. Kitamoto,et al. Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. , 2006, International journal of radiation oncology, biology, physics.
[10] L. Livi,et al. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. , 2005, International journal of radiation oncology, biology, physics.
[11] A. Garden,et al. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? , 2003, International journal of radiation oncology, biology, physics.
[12] A. Hanlon,et al. Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: the Fox Chase experience and review of the literature. , 1997, American journal of clinical oncology.
[13] K. Greven,et al. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. , 1997, International journal of radiation oncology, biology, physics.
[14] W. Mendenhall,et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control. , 1993, International journal of radiation oncology, biology, physics.
[15] S Schraub,et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] C. Terhaard,et al. The importance of vocal cord mobility in T2 laryngeal cancer. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] S. Stringer,et al. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottic larynx? , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] G. Fletcher,et al. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. , 1988, International journal of radiation oncology, biology, physics.
[19] W. F. Van den Bogaert,et al. The significance of extension and impaired mobility in cancer of the vocal cord. , 1983, International journal of radiation oncology, biology, physics.
[20] B. Cummings,et al. T2 glottic cancer: an analysis of dose-time-volume factors. , 1981, International journal of radiation oncology, biology, physics.
[21] G. Deboer,et al. Prognostic factors in T2 glottic cancer , 1980, Cancer.
[22] E. Fluur,et al. XXV Aspects on Treatment of Cancer of the Larynx , 1967, The Annals of otology, rhinology, and laryngology.
[23] F. Darrow,et al. Carcinoma of the larynx. , 1949, The Journal of the Oklahoma State Medical Association.